Literature DB >> 72108

Immunologic properties of purified Sendai virus glycoproteins.

C Orvell, E Norrby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 72108

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  15 in total

1.  Role of envelope proteins of paramyxoviruses in the modification of cell membrane antigens.

Authors:  M D Eaton
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.

Authors:  K L van Wyke Coelingh; C C Winter; E D Jorgensen; B R Murphy
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Immunoglobulin A monoclonal antibodies protect against Sendai virus.

Authors:  M B Mazanec; J G Nedrud; M E Lamm
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells.

Authors:  C Orvell; K Kristensson
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations.

Authors:  R J Avery; J Niven
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

6.  Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit.

Authors:  N Elango; M Satake; J E Coligan; E Norrby; E Camargo; S Venkatesan
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

8.  Correlation between the reactivity patterns of monoclonal antibodies to distinct antigenic sites on HN glycoprotein and their protective abilities in Sendai (6/94) virus infection.

Authors:  N Piga; N Kessler; M P Layani; M Aymard
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

9.  Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.

Authors:  M Satake; J E Coligan; N Elango; E Norrby; S Venkatesan
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

10.  Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins.

Authors:  Y Hosaka
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.